Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Arthritic Therapeutic Market, by Application
1.4.2 North America Arthritic Therapeutic Market, by Product Type
1.4.3 North America Arthritic Therapeutic Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent Strategies Deployed in the Arthritic Therapeutic Market
Chapter 5. North America Arthritic Therapeutic Market, by Application
5.1 North America Rheumatoid Arthritis Market, by Country
5.2 North America Psoriatic Arthritis Market, by Country
5.3 North America Osteoarthritis Market, by Country
5.4 North America Ankylosing Spondylitis Market, by Country
5.5 North America Others Market, by Country
Chapter 6. North America Arthritic Therapeutic Market, by Product Type
6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
6.2 North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
6.3 North America Biologics Market, by Country
6.4 North America Others Market, by Country
Chapter 7. North America Arthritic Therapeutic Market, by Country
7.1 US Arthritic Therapeutic Market
7.1.1 US Arthritic Therapeutic Market, by Application
7.1.2 US Arthritic Therapeutic Market, by Product Type
7.2 Canada Arthritic Therapeutic Market
7.2.1 Canada Arthritic Therapeutic Market, by Application
7.2.2 Canada Arthritic Therapeutic Market, by Product Type
7.3 Mexico Arthritic Therapeutic Market
7.3.1 Mexico Arthritic Therapeutic Market, by Application
7.3.2 Mexico Arthritic Therapeutic Market, by Product Type
7.4 Rest of North America Arthritic Therapeutic Market
7.4.1 Rest of North America Arthritic Therapeutic Market, by Application
7.4.2 Rest of North America Arthritic Therapeutic Market, by Product Type
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Amgen, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Novartis AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Viatris, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Trials and Approvals:
8.6.6 SWOT Analysis
8.7 Bausch Health Companies, Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Bristol-Myers Squibb Company
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 